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Abstract : Endothelin-1 is a peptide with many functions including bronchoconstric-
tion and the stimulation of fibroblasts, and myofibroblasts, and airway smooth 
muscle cell proliferation.  These functions are related to airway remodeling and 
endothelin-1 is known to be upregulated in the epithelium of patients with severe 
asthma.  We thus sought to elucidate the mechanisms underlying endothelin-1 
expression in bronchial epithelial cells in vitro.  The human bronchial epithelial cell 
line BEAS-2B was grown in culture and then treated with tumor necrosis factor-
alpha （TNF-α）, interleukin-4 （IL-4）, interleukin-13 （IL-13）, and transforming 
growth factor-beta （TGF-β）.  Expression of endothelin-1 mRNA and protein was 
quantified by real-time polymerase chain reaction and enzyme-linked immuno-
sorbent assay, respectively.  We also repressed expression of the key transcription 
factor in the pathogenesis of severe asthma, nuclear factor-kappa B （NF-κB）, 
using small interfering RNA （siRNA）.  TNF-α and TGF-β signicantly increased 
the release of endothelin-1 protein into the culture medium of BEAS-2B cells at 
24 h after treatment compared to untreated cells ; however, the Th2 cytokines, IL-4 
and IL-13, had no effect.  Endothelin-1 mRNA expression was also upregulated 
by TNF-α and TGF-β with a peak time point at 4 h after stimulation.  Finally, 
the combination of TNF-α and TGF-β synergistically increased both endothelin-1 
protein secretion and mRNA expression, and this upregulation was signicantly sup-
pressed in cells transfected with siRNA to repress NF-κB expression.  TNF-α and 
TGF-β synergistically upregulate the expression of endothelin-1 in human bronchial 
epithelial cells, possibly via the activity of NF-κB.  Our ndings thus suggest NF-
κBa as a potential therapeutic target for the regulation of airway remodeling.
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Introduction
　The pathophysiology of asthma is characterized by chronic airway inammation and remodel-
ing such as subepithelial fibrosis, deposition of extracellular matrix protein, hypertrophy and 
hyperplasia of airway smooth muscle, and goblet cell hyperplasia.  Increased bronchial wall thick-
ness caused by such airway remodeling contributes to airow obstruction and the subsequent 
treatment resistance in severe asthma 1）.
　Endothelin-1 is a 21-amino acid peptide with vasoconstrictive and bronchoconstrictive activi-
ties 2）.  It also functions to stimulate the proliferation of broblasts, myobroblasts, and airway 
smooth muscle cells, as well as the deposition of extracellular matrix and the differentiation of 
broblasts into myobroblasts 3, 4）.  These functions of endothelin 1 might therefore play a role 
in the pathogenesis of airway remodeling.  Indeed, recent studies indicate that the expression of 
endothelin-1 is increased in severe asthma and contributes to airway remodeling therein 5, 6）, while 
data from murine models of asthma corroborated that endothelin-1 contributes to airway remod-
eling 7）.  All of these studies identied bronchial epithelial cells as an important source for endo-
thelin-1 production, supported by in vitro experiments showing that cultured bronchial epithelial 
cells also produce endothelin-18）.  In the present study, we used this in vitro system to further 
investigate the mechanisms underlying endothelin-1 production in human bronchial epithelial cells.
Methods
Cell culture and reagents
　The human bronchial epithelial cell line BEAS-2B was purchased from the American Type 
Culture Collection （Manassas, VA, USA）.  This cell line was derived from non-tumor bronchial 
epithelial cells transformed with the SV40 virus 9）.  The cells were cultured in Dulbecco’s modi-
ed Eagle’s medium （DMEM）/Ham’s F12 （F12） medium supplemented with 10％ fetal bovine 
serum （FBS）, 100 U/ml penicillin, and 100 ng/ml streptomycin （Invitrogen, Tokyo, Japan） and 
maintained at 37°C in a humidified 5％ CO2 atmosphere. We purchased recombinant human 
cytokines, tumor necrosis factor-alpha （TNF-α）, transforming growth factor-beta1 （TGF-β1）, 
interleukin-4 （IL-4）, and interleukin-13 （IL-13）, from R&D Systems （Tokyo, Japan）.  Cells were 
treated with each cytokine as described below and then the supernatants and RNA from the 
cells were collected and stored at -80°C. 
Enzyme-linked immunosorbent assay（ELISA）assay for endothelin-1 protein production
　The concentrations of secreted endothelin-1 in the cell culture supernatants were measured 
using enzyme-linked immunosorbent assay （ELISA） kits （R&D Systems）.  Standards and 
samples were added to 96-well microtiter plates coated with the anti-endothelin-1 antibody. 
After incubation at room temperature for 2 h, the wells were washed 5 times with washing 
buffer.  A horseradish peroxidase-conjugated secondary antibody against endothelin-1 was then 
added to the wells and incubated at room temperature for 2 h.  The wells were washed 5 times 
with washing buffer, before adding a substrate solution （stabilized hydrogen peroxide and tetra-
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methylbenzidine） and incubating the plate at room temperature for 30 minutes to visualize the 
antibody binding.  Sulfuric acid was added to arrest the reaction, and the absorbance at 450 nm 
was measured using an ELISA plate reader （Glomax-Multi Detection System, Promega, Tokyo, 
Japan）. 
RNA purification and cDNA synthesis
　Total RNA was extracted from cells after incubation with and without the indicated reagents 
using ISOGEN （Nippon-Gene, Tokyo, Japan）.  cDNAs were synthesized from isolated RNA 
templates using a High-Capacity cDNA Archive Kit （Applied Biosystems, Tokyo, Japan）.
Real-time polymerase chain reaction （PCR）
　A pre-designed TaqMan probe for endothelin-1 was purchased from Applied Biosystems, and 
then labeled with a uorescent reporter dye （FAM） at the 5’ end and a downstream quencher 
dye （TAMRA） at the 3’ end.  The TaqMan Ribosomal RNA probe, labeled with a uorescent 
reporter dye （VIC）, was used as an internal control.  Each reaction consisted of 2X Universal 
Master Mix （Applied Biosystems）, primers, labeled probes, and 100 ng cDNA in a total volume 
of 50 µl.  Amplication conditions consisted of an initial incubation at 95°C for 10 min followed 
by 40 cycles of 95°C for 15 s and 60°C for 1 min.  Amplication and uorescence measurements 
were carried out during the elongation step using a Real-Time PCR system 7,500 （Applied 
Biosystems）.  Data are shown as fold induction of mRNA compared with non-stimulated control 
cells.
Repression of NF-κB expression with siRNA 
　To analyze the transcriptional mechanisms of endothelin-1 expression in bronchial epithelial 
cells, we focused our study on the role of nuclear factor-kappa B （NF-κB） which is a key 
transcription factor in the pathogenesis of severe asthma.  We utilized small interfering RNA 
（siRNA）-mediated repression of NF-κB expression, as previously reported 10）.  BEAS-2B cells 
were seeded into 6-well plates and allowed to grow to 50％ conuence, before being transfected 
with 50 nm siRNA for NF-κB （p65 subunit ; RELA） or scrambled RNA （negative control） 
（Applied Biosystems） plus 5 µl Lipofectamine 2,000 （Promega） and grown in DMEM/F12 with 
10％ FBS without antibiotics for 24 h.  Then, the cell media were changed to DMEM/F12 with 
10％ FBS, 100 U/ml penicillin, and 100 ng/ml streptomycin.  After another 24 h, the cells were 
incubated with or without the indicated cytokines for 4 h （for PCR） or for 24 h （for ELISA）. 
Then cells were harvested and the supernatant was collected and stored at -80°C.  
Statistical analysis
　Data were expressed as the means ± standard error of the mean （SEM）.  Statistical differ-
ences were determined by analysis of variance with a Fisher protected least signicant differences 
test. Data were analyzed with Stat-View 5.0 （Abacus Concepts, Inc., Berkeley, CA, USA）.
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Results
Increase of endothelin-1 protein production by TNF-α and TGF-β
　The cytokines used in this study were chosen because of their reported pathogenic associa-
tion with airway remodeling in asthma 1）.  We first examined the effect of each cytokine on 
the secretion of endothelin-1 into the culture medium of BEAS-2B cells.  TNF-α and TGF-
β each increased endothelin-1 secretion at 24 h after treatment （P＜ 0.05 compared with non-
treated control cells） （Fig. 1）.  In contrast, the Th2 cytokines IL-4 and IL-13 did not increase 
the secretion of endothelin-1.  We therefore focused our study on the regulation of endothelin-1 
expression by TNF-α and TGF-β and the underlying mechanisms thereof.
Time-dependent expression of endothelin-1 protein and mRNA after stimulation with TNF-α
　As an initial experiment, we observed the time course of endothelin-1 protein release into 
the cell culture medium and that of its cellular mRNA expression in response to TNF-α treat-
ment.  The peak secretion of endothelin-1 occurred at 24 h after stimulation with 10 ng/ml TNF-
α （P＜ 0.05 compared with non-treated control cells） （Fig. 2A）.  On the other hand, the peak 
expression of endothelin-1 mRNA was observed at 4 h after the same stimulation, preceding 
protein production （P＜ 0.05 compared with non-treated control cells） （Fig. 2B）.
Time-dependent expression of endothelin-1 protein and mRNA after stimulation with TGF-β
　We also analyzed the time course of endothelin-1 protein secretion and mRNA expression 
after stimulation with TGF-β （10 ng/ml）.  Peak secretion of endothelin-1 protein into the 
medium of BEAS-2B cells was observed at 24 to 72 h after stimulation with TGF-β （P＜ 0.05 
compared with non-treated control cells） （Fig. 3A）.  However, for TNF-α, the peak expression 
of endothelin-1 mRNA was detected at 4 h after TGF-β stimulation （P＜ 0.05 compared with 
non-treated control cells） （Fig. 3B）.  Therefore, we focused subsequent analyses of endothelin-1 
secretion and mRNA production at 24 h and 4 h, respectively, after stimulation with TNF-α 
and/or TGF-β.
Secretion of endothelin-1 protein and mRNA expression after stimulation with different doses of 
TNF-α
　Endothelin-1 protein secretion appeared to increase dose-dependently at 24 h after TNF-α 
stimulation of the BEAS-2B cells （P＜ 0.05 compared with non-treated control cells）, with maxi-
mum expression observed with 10-100 ng/ml TNF-α （Fig. 4A）.  Similarly, the mRNA expression 
of endothelin-1 at 4 h after stimulation was also upregulated by TNF-α in a dose-dependent 
manner （P＜ 0.05 compared with non-treated control cells） （Fig. 4B）.  Therefore, we chose the 
dose of 10 ng/ml TNF-α for subsequent endothelin-1 analyses.
Secretion of endothelin-1 protein and mRNA expression after stimulation with different doses of 
TGF-β
105Endothelin-1 Expression in Bronchial Epithelial Cells
　Endothelin-1 secretion from the BEAS-2B cells also seemed to increase does-dependently at 
24 h after TGF-β stimulation （P＜ 0.05 compared with non-treated control cells） （Fig. 5A）. 
The difference in secretion was statistically signicant between treated and control cells at 1-10 
ng/ml TGF-β, while the expression of endothelin-1 mRNA was upregulated by 10 ng/ml TGF-β 
at 4 h after stimulation （P＜ 0.05 compared with non-treated control cells） （Fig. 5B）.  Accord-
ingly and as for TNF-α, we chose the dose of 10 ng/ml TGF-β for subsequent analyses of 
endothelin-1. 
Fig. 1.   Increased endothelin-1 protein secretion into 
the medium of cultured bronchial epithelial 
cells, BEAS-2B, treated with TNF-α and TGF-
β. BEAS-2B cells were incubated with 10 ng/
ml IL-4, IL-13, TNF-α, or TGF-β cytokines 
for 24 h and the supernatants were subjected to 
ELISA for endothelin-1. The data are presented 
as the means ± SEM of three independent 
experiments ［＊P＜ 0.05 compared with non-
treated control cells （cont）］.
Fig. 2.   Time course of endothelin-1 induction with TNF-α. （A） Total amount of 
endothelin-1 protein secreted into the medium, and （B） expression of endothelin-1 
mRNA for BEAS-2B cells stimulated with 10 ng/ml TNF-α. The culture medium 
and cells were collected and subjected to ELISA or real-time PCR at the indicated 
time points after stimulation. The data are presented as the means ± SEM of three 
independent experiments （＊P＜ 0.05 compared with non-treated control cells）.
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Synergistic upregulation of endothelin-1 expression by TNF-α and TGF-β
　We next observed the effects of stimulation with a combined treatment of TNF-α and TGF-
β.  Combination treatment significantly increased the total level of endothelin-1 protein in 
the medium of BEAS-2B cells at 24 h after treatment （P＜ 0.05 compared with stimulation 
by TNF-α or TGF-β alone） （Fig. 6A）.  This synergistic stimulation of endothelin-1 was also 
observed in the mRNA expression levels （P＜ 0.05 compared with stimulation by TNF-α or 
TGF-β alone） （Fig. 6B）.
Induction of endothelin-1 expression by TNF-α is dependent upon the transcription factor NF-κB
　Finally, we explored the role of transcription factor NF-κB in the mechanisms of endothelin-1 
regulation in bronchial epithelial cells.  First, real-time PCR was used to conrm that the NF-
Fig. 3.   Time course of endothelin-1 induction with TGF-β. （A） Total amount of 
endothelin-1 protein secreted into the medium, and （B） expression of endothelin-1 
mRNA for BEAS-2B cells stimulated with 10 ng/ml TGF-β. Culture medium and 
cells were collected and subjected to ELISA or real-time PCR at the indicated 
time points after stimulation. The data are presented as the means ± SEM of three 
independent experiments （＊P＜ 0.05 compared with non-treated control cells）.
  
Fig. 4.   Endothelin-1 induction with different doses of TNF-α. （A） Total amount of 
endothelin-1 protein secreted into the medium, and （B） expression of endothelin-1 
mRNA for BEAS-2B cells stimulated with the indicated doses of TNF-α. Culture 
media were collected at 24 h after stimulation and then subjected to ELISA. Cells 
were harvested at 4 h after stimulation and subjected to real-time PCR. The data 
are presented as the means ± SEM of three independent experiments （＊P＜ 0.05 
compared with non-treated control cells）.
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κB （p65/RELA） gene was signicantly downregulated in cells transfected with the siRNA for 
NF-κB, compared with cells transfected with a negative control siRNA （scrambled） （P＜
0.05 compared with cells transfected with the negative control） （Fig. 7A）.  Both the increased 
secretion of endothelin-1 protein and the mRNA upregulation following treatment with TNF-α 
or the combination of TNF-α and TGF-β were signicantly suppressed in the NF-κB si-RNA-
transfected cells （P＜ 0.05 compared with cells transfected negative control） （Fig. 7B, C）. 
Discussion
　In this study we demonstrated that pro-inflammatory cytokine, TNF-α, and growth fac-
tor, TGF-β, could synergistically stimulate the mRNA expression and protein secretion of 
Fig. 5.   Endothelin-1 induction with different doses of TGF-β. （A） Total amount of 
endothelin-1 protein secreted into the medium, and （B） expression of endothelin-1 
mRNA for BEAS-2B cells stimulated with the indicated doses of TGF-β. Culture 
media were collected at 24 h after stimulation and then subjected to ELISA. Cells 
were harvested at 4 h after stimulation and subjected to real-time PCR. The data 
are presented as the means ± SEM of three independent experiments ［＊P＜ 0.05 
compared with non-treated control cells （cont）］. 
  
Fig. 6.   Synergistic stimulation of endothelin-1 induction with TNF- α and TGF-β. （A） 
Total amount of endothelin-1 protein secreted into the medium, and （B） expression 
of endothelin-1 mRNA for BEAS-2B cells stimulated with TNF-α, TGF-β, or the 
combination or TNF-α plus TGF-β （10 ng/ml each）. Culture media were collected 
at 24 h after stimulation and then subjected to ELISA. Cells were harvested at 4 
h after stimulation and subjected to real-time PCR. The data are presented as the 
means ± SEM of three independent experiments ［＊P＜ 0.05 compared with non-
treated control cells （cont）, ＊＊P＜ 0.05 compared to the cells stimulated with TNF-
α or TGF-β alone］.
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endothelin-1 protein from bronchial epithelial cells as measured by real-time PCR and ELISA, 
respectively.  In contrast, Th2 cytokines did not change endothelin-1 expression or secretion.  We 
further showed that these mechanisms partially depended on the transcription factor, NF-κB, by 
siRNA-mediated NF-κB knockdown experiments.
　The cytokines IL-4 and IL-13 are reportedly important in the pathogenesis of asthma, and are 
known to cause airway remodeling and severe asthma.  However, asthma is a disease encom-
passing multiple different phenotypes 11, 12）, and cytokines, such as TNF-α and TGF-β, might also 
play an important role in certain phenotypes of severe asthma.  TNF-α is a pleiotropic cytokine 
that upregulates the expression of adhesion molecules, cytokines, and chemokines in the bronchial 
mucosa of patients with asthma, implicating an important role for TNF-α in the pathogenesis of 
severe asthma 13, 14）.  Recent data also showed that TNF-α inhibits eosinophil apoptosis 15）, and 
that the TNF-α pathway could be associated with airway hyper-responsiveness in obesity, one of 
the risk factors for the severity of asthma 16）.  The exact mechanistic relationship between airway 
remodeling and TNF-α has not been claried ; however, it is possible that endothelin-1, induced 
Fig. 7.   Effects of transfection with NF-κB siRNA on the induction of endothelin-1. （A） 
Repression of NF-κB expression using siRNA in BEAS-2B cells. Downregulation of 
the NF-κB （p65/RELA） gene by transfection with siRNA was confirmed using real-
time PCR. The data are presented as the means ± SEM of three independent experiments 
（＊P＜ 0.05 compared to the cells transfected with negative control siRNA）. （B） Effects of 
NF-κB gene suppression on the total secretion of endothelin-1 protein into the medium 
and （C） the expression of endothelin-1 mRNA. BEAS-2B cells were transfected with the 
negative control （white columns） or NF-κB siRNA （black columns） and then stimulated 
with TNF-α, TGF-β, or the combination of TNF-α plus TGF-β （10 ng/ml each）. 
Culture media were collected at 24 h after stimulation and then subjected to ELISA. Cells 
were harvested at 4 h after stimulation and subjected to real-time PCR. The data are 
presented as the means ± SEM of three independent experiments （＊P＜ 0.05 compared 
to the cells transfected with the negative control; NS, not significant ; cont, control cells 
without cytokine treatment）.
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by TNF-α, might contribute to the pathogenesis of airway remodeling.
　In turn, TGF-β is a multifunctional cytokine that exerts many biological effects including 
immunosuppressive and inammation-regulatory effects.  On the other hand, TGF-β also seems 
to be pivotal in the pathogenesis of airway remodeling and severe asthma 17）, inducing brocyte 
differentiation and stimulating both fibroblast proliferation and the synthesis of extracellular 
matrix proteins 18）.  TGF-β can also initiate the epithelial-mesenchymal transition, a mechanism 
characterized by the acquisition of a mesenchymal phenotype in bronchial epithelial cells and 
observed in the epithelial cells of patients with severe asthma19）.  TGF-β is also expressed in 
eosinophils, one of the key inammatory cells in asthma, and its expression therein is upregulat-
ed in severe asthma 20, 21）.  Recent reports also indicated that TGF-β expression correlates with 
the thickening of the basement membrane in children with asthma, even though these patients 
were using inhaled corticosteroids 22）.  In concordance with this and as we demonstrated in this 
study, TGF-β might contribute to the pathogenesis of airway remodeling through the upregula-
tion of endothelin-1 expression in the bronchial epithelium.
　In this study, TNF-α and TGF-β synergistically upregulated both the expression of endothe-
lin-1 in human bronchial epithelial cells and the subsequent protein secretion from these cells, 
supporting an important role for both cytokines in the pathogenesis of airway remodeling and 
severe asthma.  These effects seemed to depend on transcription, because TNF-α and TGF-β 
stimulation also upregulated endothelin-1 mRNA expression in a synergistic manner.  To examine 
the potential transcriptional regulation further, we also tested the role of NF-κB in endothelin-1 
expression and secretion.  NF-κB is a key transcription factor for initiating inflammation in 
asthma.  Many kinds of cytokines, chemokines, adhesion molecules, and growth factors can be 
activated by NF-κB ; indeed, our studies demonstrated that NF-κB activates inflammatory 
chemokines such as CCL-11, CCL-5, CXCL-8, and CXCL-10 in bronchial epithelial cells 10, 23, 24）. 
Several reports also indicated that NF-κB is activated in the epithelium of patients with asthma 
and is related to disease severity 25, 26）.  NF-κB is also an important regulator of growth factor 
expression and cell viability.  In addition, the contribution of NF-κB to airway remodeling has 
been reported in a murine asthma model 27）.  These data are concordant with those obtained 
herein, and together implicate NF-κB as a pivotal player in the regulation of endothelin-1 in 
bronchial epithelial cells.
　Such accumulating data supports the potential for endothelin-1 as a possible therapeutic target 
of asthma.  Several antagonists, including bosentan, a dual antagonist of the endothelin receptors 
ETA and ETB, have been shown to repress airway inammation, hyper-reactivity, and remodel-
ing in a murine asthma model 28, 29）.  However, to our knowledge, only a few clinical studies 
have targeted endothelin-1 in patients with asthma.  In a pilot study to determine the effect of 
bosentan administration over four weeks in seven patients with poorly controlled asthma, Coyle 
and Metersky 30） were unable to demonstrate improvement in either lung function or asthma 
symptoms.  Thus, a longer course of therapy and larger numbers of subjects might be necessary 
for a meaningful evaluation of the efcacy of endothelin-1 antagonists in asthma.
　Taken together, our results demonstrated that TNF-α and TGF-β synergistically upregulate 
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endothelin-1 in bronchial epithelial cells, and that the transcription factor NF-κB might play an 
important role in this mechanism.  These ndings suggest that NF-κB might represent a thera-
peutic target against not only inammation, but also airway remodeling.
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